HOME >> BIOLOGY >> NEWS
ACS News Service weekly press package - May 30, 2006

ely unexpected discovery that ozone may be produced in the body. Ozone is a high-energy form of oxygen most familiar as an air pollutant. That research showed that ozone can cause pathological changes in cholesterol and other molecules in the body. The changes produce toxic compounds called "atheronals" that are present in atherosclerotic plaques removed from patients with blood vessel disease.

In their new research, scheduled for publication in the June 13 issue of Biochemistry, Paul Wentworth, Jr., and colleagues report that atheronals do have the potential to cause plaques. Atheronals accelerate or stimulate a number of processes regarded as critical for formation of atherosclerotic plaques, they found.

The Biochemistry report raises the possibility that atheronals may originate in part from ozone inhaled into the lung from polluted air. "As such, the atheronals may be a heretofore unrecognized chemical player in the known linkage between environmental pollution and cardiovascular disease," the report states.

ARTICLE #1
"Proatherogenic Effects of the Cholesterol Ozonolysis Products, Atheronal-A and Atheronal-B."

DOWNLOAD PDF:
http://pubs.acs.org/cgi-bin/sample.cgi/bichaw/asap/pdf/bi0604330.pdf
DOWNLOAD HTML:
http://pubs.acs.org/cgi-bin/sample.cgi/bichaw/asap/html/bi0604330.html

CONTACT:
Paul Wentworth, Jr., Ph.D., FRSC
The Scripps Research Institute
Phone: 858-784-2576
Fax: 858-784-2593
Email: paulw@scripps.edu, paul.wentworth@bioch.ox.ac.uk

ARTICLE #2

A dozen cloves of garlic a day keeps the doctor away?
Journal of Agricultural & Food Chemistry

The classic fairy tale Goldilock
'"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
30-May-2006


Page: 1 2 3 4 5 6 7

Related biology news :

1. ACS News Service Weekly PressPac -- May 23, 2007
2. ACS News Service Weekly PressPac -- May 16, 2007
3. ACS News Service Weekly PressPac -- May 9, 2007
4. ACS News Service Weekly PressPac -- May 2, 2007
5. ACS News Service Weekly PressPac -- April 25, 2007
6. ACS News Service Weekly PressPac -- April 18, 2007
7. ACS News Service Weekly PressPac -- April 11, 2007
8. ACS News Service Weekly PressPac -- March 28, 2007
9. ACS News Service Weekly PressPac -- March 21, 2007
10. ACS News Service Weekly PressPac -- March. 14, 2007
11. ACS News Service Weekly PressPac -- Feb. 21, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ACS News Service weekly press package May

(Date:2/24/2015)... This report analyzes the worldwide markets for Face and ... and Voice Biometrics. The report provides separate comprehensive analytics for the ... Europe , Asia-Pacific , ... and Latin America . Annual estimates and forecasts ... historic analysis is provided for these markets. Market data and analytics ...
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
(Date:3/4/2015)... Proove Biosciences , a commercial ... to announce the launch of their CME-accredited course ... of Pain”. , The continuing medical education program ... year. The focus of the program is to ... treatments, integrate appropriate pain management techniques, and incorporate ...
(Date:3/4/2015)... 2015 Vegalab announced the acquisition of Ecowin, ... year. As part of the acquisition, Ecowin rebranded itself ... his role as CEO for the company,s Korea operations. ... work alongside Koo and oversee developments at the new ... Koo founded Ecowin in 2008 to ...
(Date:3/4/2015)... 4, 2015 Lancée ... Paris en décembre 2011, l,étude collaborative ... », qui compare   l es microsphères ... sorafénib dans le carcinome hépatocellulaire avancé, a recruté ... foie avancé   ; les résultats sont attendus ...
(Date:3/3/2015)... , March 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... 2015 Global Healthcare Conference in Miami, FL ... PT. David A. Ramsay , Chief Financial Officer, will ... webcast through the "Investors" section of Halozyme,s corporate website at ... for 90 days following the event. To access the live ...
Breaking Biology Technology:Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2
Cached News: